FCMB Group Plc checks every box for a classic value investor: low multiples, strong earnings growth, and a reliable dividend. At ₦11.80, it trades on 4.6x earnings and 0.9x book value, with a 4.7% dividend yield that beats most Nigerian banks. Yet the market’s lukewarm response tells you the story isn’t that simple. FCMB’s problem isn’t earnings quality. It’s who gets to benefit from those earnings.
Earnings Are Soaring. Per-Share Value Isn’t
FY2025 was a blowout on the surface. Revenue rose 53% to ₦519.2b, net income jumped 142% to ₦176.6b, and profit margin expanded from 22% to 34%. EPS climbed from ₦2.73 to ₦4.13, a 51% increase.
But look one layer deeper and the picture changes. Net income grew 142% while EPS grew 51%. The difference is dilution. FCMB increased shares outstanding by 67% in the past year to meet CBN’s recapitalisation requirements. The bank is bigger, but each share now represents a smaller slice of the business.
This matters because valuation is always about per-share outcomes. The market can celebrate 157% earnings growth, but if shareholders see half of that in their pocket, the rerating stalls. That’s exactly what’s happened. FCMB is up 25.5% over 12 months, but it’s still underperformed the NG Banks index +100% and the broader market +140.9%.
The Dividend Looks Good, Until You Read the Fine Print
FCMB earns a 6-star rating for dividends for a reason. The 4.7% yield is high, reliable, and backed by a conservative 22% payout ratio. Over the last three years, total shareholder return hit 275%, and the stock has compounded at 31% annually despite EPS growing only 9% per year.
The risk is forward-looking. With the share base 67% larger, maintaining the same dividend per share requires materially higher total payouts. If management prioritizes capital retention for growth or further recapitalisation, dividend growth could lag. Investors buying FCMB for income need to track dividend per share, not just the yield, going forward.
A Stronger Bank, But More Leverage
The capital raise secured FCMB’s national banking licence and puts it ahead of the March 31, 2026 deadline. That removes regulatory risk and opens the door to international expansion. Operationally, the bank is efficient: gross margin sits at 99.5%, net margin at 32.6%.
But the balance sheet is more levered. Debt-to-equity is 91.6%, well above Sterling’s 61.2%. Higher leverage amplifies returns in good times and magnifies risk when funding costs rise or asset quality slips. FCMB’s low beta of 0.23 and stable 7% weekly volatility suggest the market sees it as defensive, but leverage means there’s less margin for error.
The Market Is Pricing Doubt, Not Ignorance
At 4.6x earnings, FCMB is cheaper than Sterling at 5.4x, and far below the NG market average of 20x. Community fair values cluster between ₦10.73 and ₦12.11, with the consensus at ₦11.5 – slightly below the current price. The Simply Wall St model calls it 2.6% overvalued.
That’s not because analysts missed the earnings surge. It’s because they’re discounting for dilution and execution risk. A bank can raise capital, grow assets, and report higher net income while per-share economics stagnate. Until FCMB proves it can deploy the new capital accretively, the market will treat the low multiple as justified.
What Changes the Thesis
Two things would force a rerating: per-share growth and capital deployment. If EPS growth starts tracking closer to net income growth, the dilution discount fades. If management shows that the new capital is funding high-return loans or fee-generating businesses, not just defensive liquidity, confidence returns.
The next data point is Q1’26 results on April 24. Watch the gap between net income and EPS. Watch commentary on loan yields, funding costs, and how much of the capital is already earning a return. If those numbers move in the right direction, the 4.6x P/E starts looking absurd. If not, FCMB risks becoming a bank that grows the pie while shareholders keep getting a smaller slice.
Bottom Line
FCMB is not overvalued because it’s expensive. It’s priced like it’s overvalued because the benefits of growth aren’t flowing to existing shareholders yet. The business is stronger, the dividend is real, and the licence gives optionality. But until dilution stops weighing on per-share metrics, FCMB remains a stock where the fundamentals look better than the investment case.
For now, it’s a bet on management’s ability to turn a bigger balance sheet into better per-share outcomes. The market isn’t convinced they can
